Metraipolis › archive › dc_efe4102dcc02

Effectiveness and Safety of a Supplement Containing a Pharmacologically Active Basidiomycete Mushroom for Chronic Fatigue and Post-COVID-19 Fatigue Syndrome:… — Europe PMC PMID:41558017

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/41558017
DOI
10.2196/82633
License (as archived)
solo-consultazione
Archived
2026-11-06T16:49:55.153Z
SHA-256 of the archived text
29f0e74b344ade285a05b0bd44e12a5c891d4b103843bc4f37e920abcbe73373
Stable URL of this page
https://metraipolis.com/documento/dc_efe4102dcc02

How to cite

Effectiveness and Safety of a Supplement Containing a Pharmacologically Active Basidiomycete Mushroom for Chronic Fatigue and Post-COVID-19 Fatigue Syndrome:… — Europe PMC PMID:41558017 — Europe PMC (en), https://europepmc.org/article/MED/41558017 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_efe4102dcc02 (Metraipolis archive dc_efe4102dcc02, sha256 29f0e74b344ade285a05b0bd44e12a5c891d4b103843bc4f37e920abcbe73373)
BibTeX
@misc{dcefe4102dcc02,
  title = {Effectiveness and Safety of a Supplement Containing a Pharmacologically Active Basidiomycete Mushroom for Chronic Fatigue and Post-COVID-19 Fatigue Syndrome:… — Europe PMC PMID:41558017},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41558017},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_efe4102dcc02; sha256 29f0e74b344ade285a05b0bd44e12a5c891d4b103843bc4f37e920abcbe73373},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41558017. Agents can read the archived copy with the MCP tool read_document.